Talcum Powder Legal News Articles & Interviews

Three Forks, IN: Facing about 14,000 asbestos-talc cases claiming that talc causes ovarian cancer and mesothelioma, Imerys Talc America has filed for Chapter 11 bankruptcy protection. Court records indicate that defending a single case can cost Imerys $4 million and some juries have awarded damages up to $2.75 million against the company. Imerys is the sole supplier of cosmetic talc to Johnson & Johnson.

Santa Clara, CA: Despite a number of asbestos-talc lawsuits and studies to the contrary, Johnson & Johnson still stands by its talcum powder, asserting it doesn’t cause mesothelioma or ovarian cancer because their product sold to consumers never contained asbestos. J&J says plaintiffs are using attorney-driven science along with faulty studies. On the other hand, plaintiffs have brought scientific evidence showing studies linking talc exposure to cancer, adding that the giant pharma company knew the link for decades. As for the FDA, it’s still on the fence.

Los Angeles, CA Within two weeks of each other, two juries in California failed to reach a verdict on the same issues regarding asbestos-talc claims, resulting in two mistrials. Nine votes are needed for a verdict on claims that J&J was guilty of negligence, failure to warn about the risk of asbestos and marketing defective products. On Sept 24, the sixth J&J mesothelioma trial, the Los Angeles jury was deadlocked 8-4 against J&J – one juror short of victory for plaintiff Kirk Von Salzen. Bloomerg reported that Von Salzen, a retired computer salesman, had used J&J’s talcum powder for 30 years when he was diagnosed in 2017. He was seeking over $12m in damages. Despite the result, his attorney was “satisfied” that eight jurors ruled against J&J.

Los Angeles, CA: In the sixth talcum powder-cancer trial that began last month in California, Johnson & Johnson is accused of knowing its talcum powder contained asbestos, a carcinogen known to cause mesothelioma. Plaintiff Carolyn Weirick last year was diagnosed with the rare form of terminal cancer. She claims her illness was caused by using J&J’s baby powder.

St. Louis, MO: Johnson & Johnson plans to appeal the $4.69 billion verdict awarded on July 12 to 22 women and their families who alleged that ovarian cancer cases was caused by asbestos in the company’s baby powder, and that J&J failed to warn that its talcum powder raised the risk of ovarian cancer. Experts say that J&J will argue the verdict based on insufficient scientific evidence and jurisdiction. And this asbestos-talc case is one of about 9,000 that J&J is facing.

Austin, TX: By now, most everyone following the talcum powder lawsuits against Johnson & Johnson know the company is accused of failure to warn consumers about ovarian cancer risks. What they likely don’t know is that J&J isn’t required to disclose all the ingredients in their talc recipe. Attorney Mark Mueller urges the public to demand transparency…

Ridgeland, MO: Next year and the year after, St. Louis, Missouri will be the venue for a massive showdown in the courts between Johnson & Johnson and the hundreds of women who have filed lawsuits alleging there is a direct relationship between their ovarian cancer and the use of talcum powder-based products manufactured and sold by Johnson and Johnson.

Pasadena, CA: On November 16, 2017, a jury in Los Angeles Superior Court rejected Tina Herford’s argument that Johnson & Johnson’s Baby Powder and Shower to Shower talc products caused her mesothelioma. Her lawyer remains sanguine: “J&J is still selling contaminated baby powder. It is a matter of time before juries begin holding them to account,” he said of her talcum powder lawsuit. “We just missed on the first one.”

Los Angeles, CA: Courts have reversed two talcum powder judgements against Johnson & Johnson. The talcum powder lawsuits involve a woman who was awarded $417 million in August and another case was awarded $72. Both women have died from ovarian cancer.

Los Angeles, CA: No, to answer the question recently posed by a widely-read legal publication, the recent reversal of the $417 million California verdict does not foreshadow doom for talc cases. But last week was undeniably tough for the plaintiffs in Johnson & Johnson lawsuits.